Spruce Capital and Xeraya Capital hold first close of USD150m Biogreentech Venture Fund
Spruce Capital Partners and Xeraya Capital have held the first close of MLS Capital Fund II, LP at USD150 million. MLS Capital Fund II, the successor to the USD162 million Malaysian Life Sciences Capital Fund, is co-managed by Spruce Capital Partners and Xeraya Capital, which will invest the funds in